All In Biotech

Drug Trial Radar · NCT00348933

Dietary Supplements for the Treatment of Angelman Syndrome

Efficacy of a Therapeutic Treatment Trial in Angelman Syndrome

Last checked: Nov 20, 2026Latest source record: Sep 24, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

90

Actual

Start

Jul 2006

Primary completion

Feb 2010

Study completion Feb 2010

Sponsor

Lead sponsor
University of California, San DiegoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Baylor College of Medicine; Rady Children's Hospital, San Diego; Boston Children's Hospital; Greenwood Genetic Center; Rare Diseases Clinical Research Network
First posted
Jul 6, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 day, up to 5 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. The purpose of this study is to determine the effectiveness of certain dietary supplements in treating the symptoms of AS.

Conditions

  • Angelman Syndrome
  • Nervous System Diseases

Interventions

  • BetaineDrug

    100-200 mg per kg per day by mouth with a maximum of 6 grams divided in two daily doses

  • CreatineDrug

    200 mg per kg per day with a daily maximum of 5 grams divided in two daily doses

  • MetafolinDrug

    0.5 mg per kg per day by mouth with a maximum of 8 milligrams divided in two daily doses

  • Vitamin B12Drug

    1 mg by mouth per day for all weights and ages

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Average Change in Functioning in Specific Areas of Development, Including Speech and Communications Skills, Cognitive Abilities and Daily Living SkillsTime frame: Baseline, 1 year

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Rady Children's Hospital San Diego

    San Diego, California

  • Children's Hospital Boston

    Boston, Massachusetts

  • Greenwood Genetics Center

    Greenwood, South Carolina

  • Baylor College of Medicine

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.